Molecular Cloning, Sequencing, and Biological Characterization of GRA4 Gene of Toxoplasma Gondii

Overview

Journal Parasitol Res

Specialty Parasitology

Date 2013 Apr 11

PMID 23572047

Citations 5

Authors

Hira Ram

J R Rao

A K Tewari

P S Banerjee

A K Sharma

Affiliations

Soon will be listed here.

Abstract

In the present study, GRA4 (dense granule antigen) gene of Toxoplasma gondii was cloned, sequenced, and biologically characterized. The nucleotide sequence data obtained were analyzed and submitted in GenBank database (accession no. EU660037). Analysis of nucleotide sequence of GRA4 gene revealed 99.2 % homology with the published sequence (accession no. M76432). The gene segment (open reading frame) of 1,054 bp was further amplified and re-cloned in expression vector pET-32a. The recombinant protein obtained following the expression in prokaryotic system had a molecular mass of approx. 50 kDa and showed good immunoreactivity with T. gondii sera collected from infected goats. The immunization study of the recombinant protein performed in laboratory mice and live challenge with T. gondii revealed a high level of IgG response against the tachyzoite lysate antigen (TLA) by an indirect ELISA. Protection against T. gondii challenge infection was not evident in immunized mice except for the prolongation of survival period by 2 days. Humoral immune response profile revealed initially a high level of IgG antibody, but at 1 week post-challenge, a sudden drop in the level of the antibody was appreciable. Cytokine profiling by enzyme-linked immunosorbent spot method revealed relatively high level of IFN-γ production by the rodent spleen cells followed by IL-10 and IL-4. Increase in IFN-γ production by spleen cells of immunized mice following TLA stimulation suggested direct correlation to the up-regulated Th1 cells. However, the present immunization trial failed to show any positive relationship with the protection of mice following T. gondii challenge infection.

Citing Articles

Single Cell Expression Systems for the Production of Recombinant Proteins for Immunodiagnosis and Immunoprophylaxis of Toxoplasmosis.

Solowinska K, Holec-Gasior L Microorganisms. 2024; 12(8).

PMID: 39203573 PMC: 11357668. DOI: 10.3390/microorganisms12081731.

Cloning and expression of GRA-4 recombinant protein as a toxoplasmosis diagnostic kit candidate.

Hanafiah M, Helmi T, Sutriana A, Priyowidodo D, Fihiruddin F Vet World. 2020; 13(10):2085-2091.

PMID: 33281340 PMC: 7704308. DOI: 10.14202/vetworld.2020.2085-2091.

Expression of Plasmid Encoded GRA4 Gene of RH Strain in CHO Eukaryotic Cells.

Aghdasi M, Ghaffarifar F, Forooghi F, Dalimi Asl A, Sharifi Z, Maspi N Iran J Parasitol. 2018; 13(3):392-398.

PMID: 30483330 PMC: 6243160.

Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4.

Wang Y, Wang G, Ou J, Yin H, Zhang D Parasit Vectors. 2014; 7:474.

PMID: 25301141 PMC: 4195951. DOI: 10.1186/s13071-014-0474-x.

Immunization with excreted-secreted antigens reduces tissue cyst formation in pigs.

Wang Y, Zhang D, Wang G, Yin H, Wang M Parasitol Res. 2013; 112(11):3835-42.

PMID: 23949245 DOI: 10.1007/s00436-013-3571-4.

References

Parker S, Roberts C, Alexander J . CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol. 1991; 84(2):207-12. PMC: 1535410. DOI: 10.1111/j.1365-2249.1991.tb08150.x. View

Bhopale G . Development of a vaccine for toxoplasmosis: current status. Microbes Infect. 2003; 5(5):457-62. DOI: 10.1016/s1286-4579(03)00048-0. View

Lunden A . Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. Vet Parasitol. 1995; 56(1-3):23-35. DOI: 10.1016/0304-4017(94)00670-8. View

Zhou H, Gu Q, Zhao Q, Zhang J, Cong H, Li Y . Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol Res. 2006; 100(4):829-35. DOI: 10.1007/s00436-006-0341-6. View

Gazzinelli R, Hakim F, Hieny S, Shearer G, Sher A . Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol. 1991; 146(1):286-92. View

Dlugonska H . Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotechnol. 2008; 2008:632424. PMC: 2486357. DOI: 10.1155/2008/632424. View

Nam H . GRA proteins of Toxoplasma gondii: maintenance of host-parasite interactions across the parasitophorous vacuolar membrane. Korean J Parasitol. 2009; 47 Suppl:S29-37. PMC: 2769213. DOI: 10.3347/kjp.2009.47.S.S29. View

Liu M, Yuan Z, Peng G, Zhou D, He X, Yan C . Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res. 2010; 106(5):1079-84. DOI: 10.1007/s00436-010-1742-0. View

Li W, Chen Q, Ye J, Xie Z, Chen J, Zhang L . Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses. Parasitol Res. 2011; 109(3):637-44. DOI: 10.1007/s00436-011-2296-5. View

10.

Bourguin I, Chardes T, Bout D . Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice. Infect Immun. 1993; 61(5):2082-8. PMC: 280806. DOI: 10.1128/iai.61.5.2082-2088.1993. View

11.

Mevelec M, Bout D, Desolme B, Marchand H, Magne R, Bruneel O . Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine. 2005; 23(36):4489-99. DOI: 10.1016/j.vaccine.2005.04.025. View

12.

Wu X, Lin J, Lin X, Chen J, Chen Z, Lin J . Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res. 2012; 111(5):2001-9. PMC: 3480591. DOI: 10.1007/s00436-012-3047-y. View

13.

Martin V, Supanitsky A, Echeverria P, Litwin S, Tanos T, de Roodt A . Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol. 2004; 11(4):704-10. PMC: 440599. DOI: 10.1128/CDLI.11.4.704-710.2004. View

14.

Brown C, Hunter C, Estes R, Beckmann E, Forman J, David C . Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology. 1995; 85(3):419-28. PMC: 1383915. View

15.

Gazzinelli R, Wysocka M, Hayashi S, Denkers E, Hieny S, Caspar P . Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol. 1994; 153(6):2533-43. View

16.

Debard N, Buzoni-Gatel D, Bout D . Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect Immun. 1996; 64(6):2158-66. PMC: 174050. DOI: 10.1128/iai.64.6.2158-2166.1996. View

17.

Buxton D, Uggla A, Lovgren K, Thomson K, Lunden A, Morein B . Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep. Br Vet J. 1989; 145(5):451-7. DOI: 10.1016/0007-1935(89)90053-5. View

18.

Sun X, Zou J, A A E, Yan W, Liu X, Suo X . DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. Parasit Vectors. 2011; 4:213. PMC: 3229464. DOI: 10.1186/1756-3305-4-213. View

19.

Igarashi M, Kano F, Tamekuni K, Machado R, Navarro I, Vidotto O . Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice. Exp Parasitol. 2007; 118(3):386-92. DOI: 10.1016/j.exppara.2007.10.002. View

20.

Suzuki Y, Orellana M, Schreiber R, Remington J . Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988; 240(4851):516-8. DOI: 10.1126/science.3128869. View